Literature DB >> 16911928

Genetic factors for individual administration of immunosuppressants in organ transplantation.

Song-Feng Yu1, Li-Hua Wu, Shu-Sen Zheng.   

Abstract

BACKGROUND: The immunosuppressive drugs used worldwide have a narrow therapeutic index, which results in a need to individualize the dose regimen for different recipients. The oxidative enzymes cytochrome P450 (CYP)3A and the drug efflux pump P-glycoprotein (P-gp) are two potential factors in the processes of metabolism. Pharmacogenetic study of immunosuppressive drugs has focused on these two enzymes. This review was undertaken to assess the role of single nuclear polymorphisms (SNPs) of these two enzymes in the individual administration of immunosuppressive drugs. DATA SOURCES: An English-language literature search was made using MEDLINE for articles on CYP3A and P-gp in organ transplantation.
RESULTS: The SNPs of CYP3A and P-gp are closely correlated to the large variations of cyclosporine and tacrolimus dosage between different patients, although conflicting results were obtained by some authors.
CONCLUSIONS: More studies should be conducted to elucidate further the pharmacogenetics of immunosuppressive drugs in organ transplantation, a deep understanding of which would provide an important step toward drug regimen individualization in the posttransplant therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911928

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  3 in total

1.  Perioperative genomic profiles using structure-specific oligonucleotide probes.

Authors:  Kirk J Hogan; James K Burmester; Michael D Caldwell; Quinn H Hogan; Douglas B Coursin; Dawn N Green; Rebecca M R Selzer; Thomas P Broderick; Deborah A Rusy; Mark Poroli; Anna L Lutz; Allison M Sanders; Mary C Oldenburg; James A Koelbl; Monika de Arruda-Indig; Jennifer L Halsey; Stephen P Day; Michael J Domanico
Journal:  Clin Med Res       Date:  2009-05-27

2.  Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.

Authors:  Ola Sharaki; Montasser Zeid; Pacint Moez; Nermine Hossam Zakaria; Eman Nassar
Journal:  Mol Biol Rep       Date:  2014-09-21       Impact factor: 2.316

3.  Approaching treatment for immunological rejection of living-donor liver transplantation in rats.

Authors:  Yanhu Feng; Zhijian Han; Zedong Feng; Bofang Wang; Huijuan Cheng; Luxi Yang; Yangbing Li; Baohong Gu; Xuemei Li; Yahao Li; Yumin Li; Chen Wang; Hao Chen
Journal:  BMC Gastroenterol       Date:  2020-01-13       Impact factor: 2.847

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.